1. Comparison of Intact Parathyroid Hormone, Alkaline Phosphatase, Phosphate Levels for Diagnosing Severe Metabolic Bone Disease in Infants with Severe Bronchopulmonary Dysplasia.
- Author
-
Tkach, Erin K., White, Ammie M., Dysart, Kevin C., Waber, Brenda, Nawab, Ursula S., Zhang, Huayan, and Jensen, Erik A.
- Subjects
PHOSPHATES analysis ,ALKALINE phosphatase ,LOW birth weight ,BRONCHOPULMONARY dysplasia ,CONFIDENCE intervals ,PARATHYROID hormone ,OSTEOPENIA ,REFERENCE values ,RISK assessment ,RETROSPECTIVE studies ,SEVERITY of illness index ,DESCRIPTIVE statistics ,DISEASE complications ,CHILDREN ,DIAGNOSIS ,DISEASE risk factors - Abstract
Objective We compared the accuracy of serum intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), and phosphate (phos) levels for diagnosing severe metabolic bone disease (MBD) in very low-birth-weight (VLBW) infants with severe bronchopulmonary dysplasia (BPD). Study Design Retrospective analysis of VLBW infants with severe BPD admitted between 2010 and 2012 and with ≥ 1 iPTH, ALP, and phos level collected within a similar 72-hour period. MBD severity was classified by serial radiography. Results Laboratory values were available for 65 infants, of whom 24 (36.9%) developed severe MBD. A maximum ALP > 660 IU/L was the most accurate for diagnosing severe MBD (area under the curve: 88.4%; 95% confidence interval [CI]: 77.2-94.5%). Maximum iPTH was the least accurate (optimal cut point > 130 pg/mL; area under the curve: 70.5%; 95% CI: 58.2-81.4). Conclusion Maximum ALP was more accurate than iPTH or phos for diagnosing severe MBD among preterm infants with severe BPD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF